Cargando…
Pre-existing anti-mouse immunoglobulin in a patient receiving 131I-murine monoclonal antibody for radioimmunolocalisation.
Autores principales: | Davies, A. G., Bourne, S. P., Richardson, R. B., Czudek, R., Wallington, T. B., Kemshead, J. T., Coakham, H. B. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
1986
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2001326/ https://www.ncbi.nlm.nih.gov/pubmed/3954947 |
Ejemplares similares
-
Treatment of recurrent and cystic malignant gliomas by a single intracavity injection of 131I monoclonal antibody: feasibility, pharmacokinetics and dosimetry.
por: Papanastassiou, V., et al.
Publicado: (1993) -
Dose escalation with repeated intrathecal injections of 131I-labelled MAbs for the treatment of central nervous system malignancies.
por: Kemshead, J. T., et al.
Publicado: (1998) -
Radioimmunolocalisation in breast cancer using the gene product of c-erbB2 as the target antigen.
por: Allan, S. M., et al.
Publicado: (1993) -
Comparison of anti-fetal colonic microvillus and anti-CEA antibodies in peroperative radioimmunolocalisation of colorectal cancer.
por: Blair, S. D., et al.
Publicado: (1990) -
Intrathecal administration of 131I radiolabelled monoclonal antibody as a treatment for neoplastic meningitis.
por: Moseley, R. P., et al.
Publicado: (1990)